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Abstract
Background: Chemical analysis shows that honey bees (Apis mellifera) and hive products contain many pesticides derived
from various sources. The most abundant pesticides are acaricides applied by beekeepers to control Varroa destructor.
Beekeepers also apply antimicrobial drugs to control bacterial and microsporidial diseases. Fungicides may enter the hive
when applied to nearby flowering crops. Acaricides, antimicrobial drugs and fungicides are not highly toxic to bees alone,
but in combination there is potential for heightened toxicity due to interactive effects.
Methodology/Principal Findings: Laboratory bioassays based on mortality rates in adult worker bees demonstrated
interactive effects among acaricides, as well as between acaricides and antimicrobial drugs and between acaricides and
fungicides. Toxicity of the acaricide tau-fluvalinate increased in combination with other acaricides and most other
compounds tested (15 of 17) while amitraz toxicity was mostly unchanged (1 of 15). The sterol biosynthesis inhibiting (SBI)
fungicide prochloraz elevated the toxicity of the acaricides tau-fluvalinate, coumaphos and fenpyroximate, likely through
inhibition of detoxicative cytochrome P450 monooxygenase activity. Four other SBI fungicides increased the toxicity of tau-
fluvalinate in a dose-dependent manner, although possible evidence of P450 induction was observed at the lowest
fungicide doses. Non-transitive interactions between some acaricides were observed. Sublethal amitraz pre-treatment
increased the toxicity of the three P450-detoxified acaricides, but amitraz toxicity was not changed by sublethal treatment
with the same three acaricides. A two-fold change in the toxicity of tau-fluvalinate was observed between years, suggesting
a possible change in the genetic composition of the bees tested.
Conclusions/Significance: Interactions with acaricides in honey bees are similar to drug interactions in other animals in that
P450-mediated detoxication appears to play an important role. Evidence of non-transivity, year-to-year variation and
induction of detoxication enzymes indicates that pesticide interactions in bees may be as complex as drug interactions in
mammals.
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Introduction
Chemical analysis of honey bees (Apis mellifera) and hive products
show that most managed bee colonies in North America and
Europe are repositories of a suite of chemical contaminants,
including an assortment of insecticides, acaricides, herbicides and
fungicides [1–3]. While a number of the residues detected were
insecticides, many of which are highly toxic to bees, compounds of
low acute toxicity were detected most frequently and at the highest
concentrations in both bees and hive products. Some of the most
ubiquitous contaminants of bees and bee products, coumaphos
and tau-fluvalinate [3], are abundant in the hive environment
because both are deliberately introduced as therapeutic acaricides
to control the ectoparasitic mite, Varroa destructor. Varroa is the most
serious pest of managed honey bee colonies in Europe and North
America and clearly plays a role in the recent colony losses
associated with colony collapse disorder [4–6]. Varroa weakens
colonies in two ways: directly, by consuming the hemolymph of
adult and pupal bees and, indirectly, by vectoring honey bee
viruses and causing immunosuppression in parasitized bees [7].
In the face of the serious challenges presented by Varroa,
beekeeping has become dependent on management techniques to
control mite infestations, with apicultural acaricides playing a
major role [4]. However, finding chemical control agents that
selectively kill an arthropod pest of an arthropod host poses a
unique pharmacological challenge. Synthetic pesticides that have
been used as acaricides include the pyrethroid tau-fluvalinate
(Apistan and Mavrik), the organophosphate coumaphos (Check-
Mite+, Perizin and Asuntol 50), the formamidine amitraz (Apivar
and Taktik) and the pyrazole fenpyroximate (Hivastan and
FujiMite). Natural products are also used for Varroa control,
including the monoterpenoid thymol (ApilifeVar and ApiGuard)
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and the organic acids, oxalic acid (Oxivar) and formic acid
(MiteAway Quick Strips). There is little doubt that bees can benefit
from reduced Varroa populations through the effective use of
acaricides in combination with other management techniques
[4,6,7]. In a chemical survey of honey bee colonies suffering from
colony collapse disorder, the healthiest colonies were found to
have higher concentrations of one acaricide, coumaphos [8].
The effectiveness of tau-fluvalinate [9] and coumaphos [10] has
waned as Varroa populations have developed resistance to these
acaricides. However, tau-fluvalinate and coumaphos remain
common contaminants in the hive environment, partially as a
result of continued application by beekeepers, and partially due to
their lipophilic properties which lead to accumulation and
persistence in beeswax [1,11]. Both coumaphos and tau-fluvalinate
survive the wax recycling process and are present in newly
manufactured wax foundation [3,12]. While amitraz itself does not
accumulate in bee colonies [13], the amitraz metabolite 2,4-
dimethyl formamide (DPMF) has been detected in both bees and
wax [3]. Oxalic acid is a natural product that can be found in
honey and as an allelochemical in plants [14], though not at
concentrations used for Varroa control. While thymol and other
monoterpenoids may be naturally present in floral sources at low
concentration, the high concentrations needed for acaricidal
activity may noticeably contaminate honey and wax [12,15].
With the wide range of acaricides currently in use and the
continued presence of lipophilic acaricides in beeswax, it is quite
likely that bees will be exposed to multiple acaricides simulta-
neously.
In addition to the acaricides, beekeepers may also apply
antimicrobial drugs to control bacterial and microsporidial
pathogens. Fumagillin (Fumadil-B) is fed in sucrose syrup to
control infection by the microsporidian gut pathogens Nosema apis
and Nosema ceranae. Oxytetracycline (TerramycinTM) and tylosin
(TylanTM) are applied in powdered sugar or syrup to control
American foulbrood (Paenibacillus larvae) and other bacterial
infections. To protect harvested honey from contamination many
antimicrobial drugs and acaricides are subject to a withholding
period during which these therapeutics cannot be applied. As such,
beekeepers are left with a relatively narrow window during which
antimicrobial or acaricide applications are possible, potentially
leading to a situation where multiple treatments are applied
simultaneously.
In addition to compounds applied by the beekeeper, bees may
also be exposed to plant protection products applied to flowers and
flowering crops. Fungicides are the most abundant and common
of the plant protection products found in bees and bee products
because fungicides can be applied during bloom when bees are
present [3,8,16]. While fungicides generally appear safe for adult
bees [17], these compounds may, in certain situations, produce
harmful effects [18]. For instance chlorothalonil (Bravo), the most
commonly detected fungicide in bees and bee products [3], was
found in ‘‘entombed pollen’’ in colonies suffering from colony
collapse disorder [19]. Larval and pupal mortality has been
reported in bees exposed to the fungicides pyraclostrobin and
boscalid, which together constitute Pristine [16]. There are also
documented interactions between the sterol biosynthesis inhibiting
(SBI) fungicides and pyrethroid insecticides in honey bees [20–22].
For example, prochloraz is a SBI fungicide that functions through
the inhibition of fungal cytochrome P450-monooxygenase (P450)
mediated synthesis of ergosterols. Prochloraz has been shown to
inhibit detoxicative P450 activity in honey bees as well,
particularly in relation to detoxication of pyrethroid pesticides
[20,21,23,24]. Pristine and a variety of SBI fungicides are used
during bloom on almond orchards, when bees are present, and
have been detected in pollen samples [3,16].
With the potential for managed honey bees to experience
simultaneous exposure to acaricides, antimicrobials and fungicides
it is important to consider the potential for harmful interactions
between these compounds. Any interactions observed could
provide an insight into honey bee physiology and will shed light
on bees’ mechanisms of tolerance for both natural and synthetic
xenobiotics. The present study aims to test for interactions
between these most abundant contaminants of the hive environ-
ment using pair-wise lethal dose bioassays in which a sublethal pre-
treatment with one acaricide, fungicide or antimicrobial is
followed by a series of lethal doses of an acaricide. Mortality
counts were then used to fit log-probit regression lines and
determine lethal dose values (LD50s). Acaricides were also
combined with model enzyme inhibitors to characterize the
classes of detoxicative enzymes that may be the basis for
interactive effects.
Bliss [25], recognized three principal types of interactive effects
that pesticide or drug combinations may elicit [26]. If no
interaction occurs, and a combination is found to be only as
deadly as its most toxic constituent, then the components of a
mixture are understood to act independently. Such ‘‘independent
joint action’’ is the null hypothesis for the experiments presented
here and is characterized by acaricide toxicity that is unchanged
by prior exposure to any other compound.
Interactive effects between compounds are observed when the
toxicity of a drug or pesticide combination is either more or less
toxic than expected based on the toxicity of the most toxic
constituent. In the context of these experiments an interactive
effect is defined as a change in the toxicity of an acaricide
following sublethal pre-treatment with a fungicide, antimicrobial
drug or another acaricide. An agonistic interaction is defined by
the elevated toxicity of a drug or pesticide combination, while an
antagonistic interaction is characterized by decreased toxicity.
Interpreting the biological basis of interactive effects between
compounds requires that the mode of action of the drugs or
pesticides are known. Additive agonistic interactions are most
likely to occur when different compounds work through the same
mode of action. Synergistic agonistic interactions probably occur
when the compounds work through different modes of action. The
mode of action for each compound is listed in Figure 1 and 2 for
each acaricide, fungicide and antimicrobial compound [27–34].
Materials and Methods
Bees were first treated with a sublethal dose of either an
acaricide, a fungicide, an antimicrobial drug, or an enzyme
inhibitor. Bees were then treated with a range of lethal doses of an
acaricide to estimate the dose-response curve. Sublethal pre-
treaments included: six acaricides (tau-fluvalinate, coumaphos,
fenpyroximate, amitraz, thymol and oxalic acid); eight fungicides
of which three were non-SBI (pyraclostrobin, boscalid, chlorotha-
lonil) and five were SBI fungicides (prochloraz, propiconazole,
fenbuconazole, metconazole and myclobutanil); three antimicro-
bials (oxytetracycline, tylosin and fumagillin); and three enzyme
inhibitors (diethyl maleate, S,S,S-tributylphosphorotrithioate, and
piperonyl butoxide). Lethal doses of five acaricides (i.e. all except
oxalic acid) were applied as a second treatment. We tested 25 of
the 666 possible acaricide-acaricide combinations, 24 of the 665
fungicide-acaricide combinations, 15 of the 663 antimicrobial-
acaricide combinations and 9 of the 663 enzyme inhibitor-
acaricide combinations. The acaricide oxalic acid was never used
as a lethal agent in pairwise combinations because it was not
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possible to deliver a lethal dose of this compound in the
standardized volume of solvent. Enzyme inhibitors were not tested
with tau-fluvalinate or coumaphos as these combinations have
been tested previously [22,35]. The combination of pyraclostrobin
and coumaphos was tested, but insufficient data were collected to
allow for a meaningful comparison. The fungicides propiconazole,
fenbuconazole, metconazole and myclobutanil were tested in
combination with a single acaricide, tau-fluvalinate.
Chemicals
Technical grade chemicals were used for all trials, with the
exception of the antimicrobial drugs. The acaricides coumaphos,
fenpyroximate and tau-fluvalinate were obtained from Chem
Services Inc. (West Chester, PA), thymol from Aldrich Chemical
Co. (Milwaukee, WI) and oxalic acid from Fisher Scientific
(Rochester, NY). The model enzyme inhibitors piperonyl butoxide
(PBO) and diethyl maleate (DEM) were obtained from Acros
Organics (Morris Plains, NJ) and S,S,S-tributylphosphorotrithioate
(DEF) from Chem Services. The fungicides boscalid, pyraclostro-
bin, prochloraz, fenbuconazole, metconazole, myclobutanil and
propiconazole were also purchased from Chem Services, and
chlorothalonil from Fluka Analytical (St. Louis, MO). All
chemicals were serially diluted in HPLC-grade acetone for topical
application.
Figure 1. Median lethal dose (LD50) of acaricides to honey bees in 2009 following sublethal treatment with acaricides, fungicides, or
detoxicative enzyme inhibitors. Confidence intervals (95%) are indicated below the LD50 values. Significant differences compared to the control
treatment are indicated with a superscript letter: a = significant pre-treatment effect, b = significant pre-treatment*acaricide dose effect (Table S1).
LD50 values taken from previous work: {= [35], {= [22]. Names for classical enzyme inhibitors are abbreviated as follows DEM=diethyl maleate,
DEF = S,S,S-tributylphosphorotrithioate, PBO=piperonyl butoxide. A dash ‘‘2’’ indicates an LD50 that could not be calculated because of insufficient
data.
doi:10.1371/journal.pone.0054092.g001
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Insects
Fourteen honey bee colonies maintained at the University of
Nebraska – Lincoln East Campus provided bees for bioassays
conducted from April – September 2009 and 2010. Colonies were
requeened in 2010 with naturally mated Italian queens (C. F.
Koehnen & Sons, Inc., Glenn, CA). Bacterial brood diseases were
prevented with Terramycin (oxytetracycline) treatments in March
of both years. Nosema spp. infection was controlled using
Fumagilin-B (fumagillin) fed in March 2009. Apiguard and oxalic
acid were the only acaricides used in the apiary to control Varroa
populations during the four years prior to conducting this study.
Frames of late-stage brood were collected from these colonies
and placed in a dark, humid incubator (Darwin Chambers Co., St.
Louis, MO, model H024) at 34uC. Newly emerged adults were
brushed from frames daily into screened wooden cages
(21614612 cm) and weighed as a group to estimate the number
of bees. Each cohort of 200–800 bees was provisioned with 1:1 (w/
w) granulated sugar dissolved in water and held for 3–4 days in the
incubator.
Pre-treatment with Sublethal Doses of Acaricide,
Fungicide, Antimicrobial Drug or Inhibitor
Each treatment series was conducted using 3–4 day-old adult
worker bees divided into 8–13 subgroups of 20 bees each. Bees
were narcotized with carbon dioxide and each subgroup was
placed in a separate wax-coated paper cup (177 cm3; Solo S306,
Highland Park, IL) covered with cotton cheesecloth and secured
with two rubber bands. A maximum sublethal pre-treatment of an
acaricide, fungicide, enzyme inhibitor, or solvent control, was then
applied to bees in all subgroups. Model enzyme inhibitor pre-
treatments were applied to bees at the following doses: 100 mg
DEM, 10 mg DEF or 10 mg PBO [35]. Sublethal doses used as
pre-treatment for acaricides were determined in preliminary
bioassays or previous studies [22] and corresponded to doses less
than or near the LD10 values determined in the current
experiment. Acaricide pre-treatments applied to each bee were:
1 mg tau-fluvalinate, 3 mg coumaphos, 1 mg fenpyroximate, 1 mg
amitraz, 10 mg thymol and 100 mg oxalic acid. Sublethal fungicide
pre-treatment doses for each bee were: 10 mg chlorothalonil, 10 mg
prochloraz, 10 mg pyraclostrobin, 20 mg boscalid, and 10 mg
pyraclostrobin together with 20 mg boscalid to replicate the ratio
of active ingredients in Pristine. All doses were delivered topically
in 1 ml of acetone and applied to the thoracic notum using a 50 ml
syringe fitted in a repeating dispenser (Hamilton PB-600, Reno,
NV). A control pre-treatment consisting of 1 ml of pure acetone
was also included.
Bioassays testing the potential for interactive effects between
tau-fluvalinate and three different doses of the SBI fungicides,
prochloraz, fenbuconazole, metconazole, myclobutanil, pro-
chloraz and propiconazole, plus PBO, were performed in 2010.
To standardize for the different molecular weights of PBO and the
SBI fungicides bees were pre-treated at eqimolar dose levels: 0.1, 1
or 10 nanomoles fungicide per bee (corresponding to approxi-
mately 0.03, 0.3 and 3 mg per bee). Acetone was also applied as a
pre-treatment control.
Bees receiving formulated antimicrobial drug pre-treatments
were fed Duramycin-10 (40% oxytetracycline, Durvet, Blue
Springs, MO, USA), Tylan (100% tylosin, Elanco, Greenfield,
IN, USA) and Fumagilin-B (2.1% fumagillin, Medivet, Mande-
ville, LA, USA), dissolved in 50% sucrose water and fed to bees at
a concentration of 1 mg/ml oxytetracycline active ingredient (a.i.),
1 mg/ml tylosin (a.i.) and 0.5 mg/ml fumagillin (a.i.). Drug
feeding began 24 h prior to acaricide treatment and continued
until mortality was scored. The sublethal concentrations used are
similar to label recommendations for application of these drugs to
whole colonies. The drugs in 50% sucrose water, and a sucrose
water control, were fed to large groups of bees for the first 24 h of
exposure through 20 ml glass scintillation vials covered with
cotton cheesecloth, which were weighed before and after feeding
to determine drug consumption. After acaricide treatment drugs in
50% sucrose water were provided in punctured 1.5 ml micro-
centrifuge tubes.
Acaricide Dose-response Determination
Groups of pre-treated bees were allowed to recover for 1 h to
minimize mortality due to extended carbon dioxide anaesthetiza-
tion. Each subgroup of approximately 20 bees, of the 8–13 dose-
groups in the bioassay, was then anaesthetized again and treated
topically with either an acetone solvent control or one of a range of
7–12 acaricide doses, including doses eliciting 0% and 100%
Figure 2. Median lethal doses (LD50) of acaricides to honey bees in 2010 fed antimicrobial drugs used in beekeeping. Confidence
intervals (95%) are indicated below the LD50 values. Significant differences compared to the respective treatment are indicated with a superscript
letter a = significant pre-treatment effect, b = significant pre-treatment*acaricide dose effect (Table S2).
doi:10.1371/journal.pone.0054092.g002
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mortality, and at least three doses causing intermediate mortality.
After treatment sucrose water was provided to groups of treated
bees through a punctured 1.5 ml microcentrifuge tube following
dosing, and bees were returned to the 34uC incubator. Mortality
was scored at 24 h after treatment with all acaricides except
fenpyroximate. Preliminary experiments showed that mortality
was similar at both 24 and 48 h following treatment for acaricides
except fenpyroximate. Immobile bees were scored as dead.
Treatment series with greater than 5% mortality in the solvent
control group were removed from analyses. At least three replicate
treatment series were performed for each combination of pre-
treatment and acaricide. Separately diluted acaricide dose series
and bees taken from different colonies were used for each replicate
treatment.
Statistical Analyses
Lines were fitted to dose-mortality data on a log-probit scale for
each pretreatment-acaricide combination using ‘glm’ in the R
statistical package [36]. From these lines the lethal dose 50%
(LD50) values and accompanying 95% confidence intervals were
calculated using Fieller’s method, with correction for heterogeneity
where appropriate [37]. Interactive effects between acaricides and
the various pre-treatments were determined with pairwise tests
comparing the dose-response lines for bees receiving pre-
treatments with bees receiving a control pre-treatment using a
test analogous to ANCOVA [26]. The full model, which includes
the dose of acaricide as a covariate, pre-treatment as a categorical
factor and the interaction between acaricide dose and pre-
treatment, was compared with two simplified models (Figure 3). A
process of model simplification was undertaken in which the
explanatory power of model terms was assessed by reference to the
likelihood ratio [38]. The first simplified model lacks the
interaction term and tests the interaction between pre-treatment
and acaricide dose, essentially testing for differences in the slope of
the two dose-response lines (also known as a test of the ‘‘hypothesis
of parallelism’’ [26]). A significant change in slope, as determined
by a significant ‘‘dose by pre-treatment’’ interaction, may indicate
competitive inhibition between the pre-treatment and acaricide
[26]. The second simplified model lacks the pre-treatment factor
entirely and was used to test the effect of pre-treatment on
acaricide toxicity (also known as the ‘‘hypothesis of equality’’ [26]).
A significant pre-treatment effect is evidence of an agonistic or
antagonistic interaction between the two treatments.
Statistical significance for the model comparisons was deter-
mined by comparing likelihood ratios, corrected for heterogeneity,
against an F-distribution [26,38]. P-values for the 73 pairwise
comparisons were corrected using the Holm-Bonferroni procedure
(Figures 1 and 2). The 15 pairwise comparisons between tau-
fluvalinate and SBI fungicides were separately corrected for
multiple comparisons. A sample R script showing the analysis is
available (Methods S1).
Results
The relative toxicity of topical application of the five acaricides
to bees receiving the control pre-treatment, from most to least
toxic, was amitraz.fenpyroximate.tau-fluvalinate.couma-
phos.thymol in 2009 (Figure 1 and Table S1). In 2010, the
pattern of toxicity was similar, but fenpyroximate was found to be
the most toxic acaricide and amitraz the second most toxic
(Figure 2 and Table S2). Tau-fluvalinate, using identical methods,
was more toxic to bees in 2010 than in 2009 (based on non-overlap
of 95% confidence intervals) (Figures 1 and 2). Fenpyroximate also
appeared to be more toxic to bees in 2010, though bees in 2010
were not subjected to acetone pretreatment.
The different acaricides varied greatly in their propensity for
interaction with other compounds. Tau-fluvalinate interacted with
most other compounds tested, including all 5 acaricides, 8 of 9
fungicides or a fungicide combination, and 2 of 3 antimicrobial
compounds. Fewer interactions were observed with coumaphos,
fenpyroximate and thymol. Coumaphos interacted with 3 of 5
acaricides, 1 of 4 fungicides and none of the 3 antimicrobials.
Fenpyroximate interacted with 3 of 5 acaricides, 2 of 5 fungicides
and 2 of 3 antimicrobials. Thymol interacted with 3 of 5
acaricides, 2 of 5 fungicides and none of the 3 antimicrobials.
Amitraz did not interact with any fungicides or antimicrobials, but
did demonstrate an antagonistic interaction with a single acaricide,
oxalic acid.
Approximately half of the acaricide-acaricide (15 of 25) and
acaricide-fungicide (13 of 28) combinations tested showed
evidence of interactions, nearly all of which were agonistic and
resulted in increased acaricide toxicity (Figures 1 and 4). Four
interactions were detected among the 15 antimicrobial-acaricide
combinations tested, two of which were antagonistic interactions
with fenpyroximate (Figure 2). Bees fed oxytetracycline demon-
strated no change in tau-fluvalinate toxicity at the LD50 level, but
a significant increase in the slope of the fitted dose-response line
was observed. Bees fed antimicrobial drugs as a pre-treatment
consumed 5.4460.67 ml sugar water/bee/day, regardless of drug
content (ANOVA, p.0.05, N= 27).
Piperonyl butoxide, a model P450 inhibitor, and DEF, a model
carboxylesterase inhibitor, both increased the toxicity of fenpyr-
oximate, but not amitraz or thymol (Figure 1).
Figure 3. Plot of log-transformed dose and probit-transformed
honey bee mortality data for tau-fluvalinate toxicity after
oxalic acid or control pre-treatments. Symbols represent raw
mortality and solid lines indicate lines fitted using the full model.
Dotted lines represent 95% confidence intervals for each line fit with
the full model. Dashed green lines were fitted using the same slope for
both pre-treatments. The dashed blue line was fitted with combined
data from both pre-treatments. Likelihood ratio tests comparing the full
model and the reduced models were used to determine pre-treatment
effects and pre-treatment * dose effects.
doi:10.1371/journal.pone.0054092.g003
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There was no single pre-treatment that interacted with all
acaricides, although oxalic acid pre-treatment caused an interac-
tive effect with all acaricides except coumaphos. Three compounds
did not interact with any acaricide tested: the antimicrobial drug
tylosin, the enzyme inhibitor DEM, and the fungicide boscalid.
The most potent agonistic interaction observed in the first year
of the study was between prochloraz and tau-fluvalinate (Figure 1).
To determine if similar interactions occur between tau-fluvalinate
and other more widely used SBI fungicides, four additional
fungicides in this class (propiconazole, fenbuconazole, metcona-
zole, and myclobutanil) were tested in combination with tau-
fluvalinate (Figure 4 and Table S3) in the second year of the study.
Antagonistic interactions were observed between tau-fluvalinate
and 3 of 5 SBI fungicides when pre-treated with 0.1 nmol per bee.
Tau-fluvalinate became more toxic (1.4 to 2.3-fold) when bees
were pre-treated with any of the 5 fungicides or PBO at the
1 nmol dose, and much more toxic (12 to 74-fold) at the 10 nmol
dose. An interaction between tau-fluvalinate and PBO (5.8-fold)
was only observed at the 10 nmol dose level.
Discussion
For each major group of toxicants applied in combination with
acaricides – model enzyme inhibitors, acaricides, fungicides, and
antimicrobials – we first consider the physiological implications of
our results, especially as they relate to the involvement of
detoxification enzyme systems, as well as non-transitivity that
was observed in some of the interactions. Finally, we address the
environmental relevance of our findings for assessing risks of the
toxicants to bee health.
Model Enzyme Inhibitor Interactions
The agonistic interactions observed between PBO and tau-
fluvalinate [35], coumaphos [22] and fenpyroximate imply that
P450 enzymes play a role in detoxifying these acaricides in honey
bees. Heterologous expression of three honey bee P450 enzymes
demonstrated that P450s are capable of metabolizing both tau-
fluvalinate and coumaphos in vitro [39]. Agonistic interactions with
DEF suggest that tau-fluvalinate, coumaphos and fenpyroximate
are also detoxified through carboxylesterase activity. No interac-
tions were observed between DEM and the acaricides. Therefore,
either glutathione-S-transferase enzyme activity is not important
for the detoxication of acaricides or DEM is not an effective
inhibitor of the relevant enzymes in honey bees.
Thymol and amitraz did not interact with any of the inhibitors,
which indicates that detoxication is not important for bees’
tolerance of these compounds. However, despite their unchanged
toxicity in the presence of enzyme inhibitors, both thymol and
amitraz have the potential to interact with detoxicative enzymes
[40,41] and may interfere with detoxication of other xenobiotics.
Acaricide-acaricide Interactions
The cluster of interactions observed between tau-fluvalinate,
coumaphos and fenpyroximate, all of which appear to be
detoxified by P450s and carboxylesterases, suggest that interac-
tions between these compounds may be occurring because these
acaricides interact with detoxicative enzymes [22,39]. However,
not every combination of these acaricides caused an interaction.
Since acaricides were used both as treatments and as pre-
treatments, we were able to investigate the temporal transitivity of
the interactions. A combination is ‘transitive’ if the same effect
occurs irrespective of the order of exposure and ‘non-transitive’ if
an interaction is only observed when one of the pair of compounds
is applied first. A non-transitive interaction was observed between
tau-fluvalinate and fenpyroximate. While fenpyroximate pre-
treatment increased the toxicity of tau-fluvalinate 8-fold, the
opposite was not true. Tau-fluvalinate pre-treatment did not
significantly change the toxicity of fenpyroximate. The non-
transitivity exhibited between fenpyroximate and tau-fluvalinate
may indicate that fenpyroximate can competitively inhibit the
specific P450 isozymes involved in tau-fluvalinate detoxication
[39] while tau-fluvalinate does not interact with the specific P450s
that allow bees to tolerate fenpyroximate exposure.
The toxicity of thymol increased following pre-treatment with
either tau-fluvalinate or coumaphos. Since it is not known how
bees tolerate thymol, it is difficult to speculate about the basis for
these interactions. Coumaphos toxicity was unchanged by thymol,
but tau-fluvalinate toxicity was transitively increased when thymol
was applied as a pre-treatment. Monoterpenoids, like thymol, have
been shown to inhibit P450 activity in human liver microsomes
[40], so this agonistic interaction may be a result of thymol
inhibition of the P450s on which tolerance of tau-fluvalinate
depends.
Amitraz participated in three non-transitive acaricide-acaricide
interactions. The toxicity of amitraz was unchanged when bees
were pre-treated with tau-fluvalinate. However, amitraz pre-
treatment increased the toxicity of tau-fluvalinate 5-fold. Interac-
tions between formamidines and pyrethroids are known in other
insects and may be due to synergism at the target site through
cooperative binding [42], or through inhibition of pyrethroid
detoxication, through inhibition of P450s or carboxylesterases
[41].
Amitraz is bioactivated through a hydrolysis reaction to DMPF
which is an octopamine receptor agonist [29,43]. Bees may
tolerate amitraz as an acaricide because they are poor at amitraz
bioactivation, possibly due to the paucity of genes that encode
P450s and carboxylesterases in the honey bee genome [44].
Despite the apparent lack of amitraz bioactivation in bees, this
compound may have some affinity for the P450 enzymes that are
important for tau-fluvalinate and fenpyroximate detoxication.
In one of the few antagonistic interactions observed, oxalic acid
pre-treatment reduced the toxicity of amitraz nearly four-fold.
Figure 4. Median lethal doses (LD50) for tau-fluvalinate in
honey bees pre-treated with piperonyl butoxide (PBO) or a
sterol biosynthesis inhibiting (SBI) fungicide at three dose
levels. Significant differences compared to the control treatment are
indicated with a superscript letter a = significant pre-treatment effect,
b = significant pre-treatment*acaricide dose effect (Table S3).
doi:10.1371/journal.pone.0054092.g004
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However, this interaction may be an artifact of the methods used.
Amitraz was applied to the same location on the thoracic notum as
the oxalic acid pre-treatment, which may have caused degradation
of amitraz, which is known to undergo hydrolytic breakdown
under acidic conditions [45], while tau-fluvalinate and coumaphos
do not [46]. All other acaricides showed some agonistic effects with
oxalic acid, possibly due to increased cuticular penetration caused
by the abrasive effect of oxalic acid crystals on the epicuticle or
because of the elevated production of reactive oxygen species
initiated by oxalic acid [47,48]. Future studies may seek to avoid
the effects of local site interactions by using different application
sites or different routes of administration.
Environmental Relevance of the Observed Acaricide-
acaricide Interactions
High sublethal doses were deliberately chosen as pre-treatments
to make the magnitude of any interactive effect between the pre-
treatment and acaricide as large as possible. However, to
determine the hazard posed by acaricide interactions in bee hives,
the actual exposure bees receive when treated with formulated
acaricides must be considered. Margins of safety for each acaricide
formulation can be estimated by dividing the dose estimated to
cause 10% mortality (LD10) by the estimated daily dose. The LD10
can be determined from the fitted dose response lines (Table S1).
The daily dose can be estimated by first determining the amount
of active ingredient present in each acaricide formulation,
correcting this value by the amount of active ingredient available
for uptake by the bees (e.g. 10% of the total acaricide content in
strip formulations is taken up by bees [49,50]) and dividing this
quantity by the number of days the acaricide formulation is
present in the hive. The estimated daily dose calculated in this way
can be validated using published pesticide residue data [3,51].
Based on these calculations, coumaphos and tau-fluvalinate
formulations carry the largest margins of safety for honey bees
(43- and 29-fold, respectively), while fenpyroximate, amitraz,
thymol and oxalic acid formulations have narrower margins of
safety (2.0 to 7.8-fold). A consequence of the great differences in
margins of safety between acaricides is that the potent interactions
observed in this study with tau-fluvalinate and coumaphos may be
less harmful in the real world than apparently milder interactions
observed with fenpyroximate and thymol.
Beeswax is the ultimate sink for the lipophilic pesticides in the
beehive and beeswax may contain up to 94 ppm coumaphos and
204 ppm tau-fluvalinate [3,49]. Both coumaphos and tau-
fluvalinate are quite stable in the wax component of the hive
where they can persist for years and even increase in concentration
when acaricide treatments are repeated [50,52,53]. Bees are also
exposed to the bioactivated breakdown product of amitraz,
DPMF, at concentrations as high as 43 ppm in wax [3]. Thymol
has been detected in wax at concentrations as high as 4753 ppm
[12]. Coumaphos and tau-fluvalinate survive the wax recycling
process and are present in newly manufactured wax foundation
[3,12]. Acaricide contamination is pervasive in managed colonies,
but it is unknown what fraction of these compounds can leach out
of wax and into adult bees and developing brood. The burden of
acaricides and other pesticides in old wax brood comb is sufficient
to reduce brood survival [54], delay the development time of
larvae and reduce the lifespan of adult workers [55], and increase
the susceptibility of adults to Nosema infection [56]. Combinatorial
effects between acaricides and other pesticides present in the wax
[3] may be contributing to the observed negative effects of old
comb.
Fungicide-acaricide Interactions
In 2009 experiments the SBI fungicide prochloraz produced an
almost 2000-fold increase in the toxicity of tau-fluvalinate. Tau-
fluvalinate, coumaphos and fenpyroximate – all acaricides for
which P450-mediated detoxication was implicated through
synergistic interactions with PBO – also showed a synergistic
interaction with prochloraz. These results confirm previous reports
of interactions between pyrethroid insecticides and prochloraz
through P450s [20], and extend those findings to show that this
fungicide can affect the metabolism of acaricides as well as field-
applied pesticides.
Because of the potent interaction observed between pro-
chloraz and tau-fluvalinate, additional P450-interacting SBI
fungicides were tested that are extensively used in a variety of
cropping systems. The SBI family of fungicides are known to be
present in bee-collected pollen, wax and in bees themselves
[2,3,57]. Five SBI fungicides demonstrated synergism with the
pyrethroids alpha-cypermethrin and lambda-cyhalothrin in bees
[23]. We found that a similar suite of SBI fungicides could
interact synergistically with the pyrethroid tau-fluvalinate, likely
through inhibition of P450s, when administered at 1 or 10 nmol
of fungicide per bee. Unexpectedly, an antagonistic interaction
was observed at the lowest fungicide doses (0.1 nmol or
approximately 0.03 mg per bee). This antagonism suggests that,
in addition to inhibiting bee P450 enzymes, the SBI fungicides
may also induce P450 gene expression at low levels of exposure,
including the genes encoding P450 isozymes that are involved in
tau-fluvalinate detoxication [39]. Low doses of P450 inhibitors
have been found to induce P450 gene expression in other
insects [58] and SBI fungicides can induce P450 enzyme activity
in mammals [59]. Quercetin, a pollen flavonol that is known to
interact with bee P450s [60], caused a similar reduction in tau-
fluvalinate toxicity in bees [61].
Pre-treatment of bees with the fungicide chlorothalonil
increased the toxicity of both thymol and tau-fluvalinate.
Chlorothalonil is a multi-site action fungicide in the chloronitrile
family and is metabolized through P450 activity to 4-hydroxy-
2,5,6-trichloroisophthalonitrile. This metabolite is both more toxic
and more likely to cause oxidative stress than the parent
compound [62,63]. Competitive P450 inhibition of tau-fluvalinate
detoxication may account for this observed interaction as well.
Chlorothalonil has previously been shown to have an interactive
effect with alpha-cypermethrin and lambda-cyhalothrin, two
pyrethroids, in bees [23].
Pyraclostrobin and boscalid applied together in a blend like
Pristine moderately increased the toxicity of tau-fluvalinate.
When applied individually, however, only pyraclostrobin had an
effect. Both boscalid and pyraclostrobin kill fungi through the
inhibition of respiration by blocking mitochondrial electron
transfer at complexes II and III, respectively [64,65]. Pyraclo-
strobin also moderately increased the toxicity of fenpyroximate,
which is itself an inhibitor of mitochondrial respiration at
complex I [66]. Fenpyroximate, pyraclostrobin and boscalid in
combination have been hypothesized to harm bees by starving
them of energy through inhibition of oxidative phosphorylation.
Alternatively, the interaction observed between fenpyroximate
and pyraclostrobin may be the product of increased oxidative
stress caused by their interference with mitochondrial electron
transport [67]. Increased mortality related to oxidative stress
may also explain the interaction observed between tau-
fluvalinate and pyraclostrobin, as pyrethroids can also cause
increased production of reactive oxygen species [68]. Other
respiration-inhibiting fungicides including iprodione and vinclo-
zlin [32] may also be of concern as these compounds have been
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found at high concentration in chemical analyses of bees and
bee products [3].
Environmental Relevance of Fungicide-acaricide
Interactions
Consumption of contaminated pollen is the most likely route of
exposure to fungicides [57]. Assuming a colony consumes an
average of 20 kg of pollen per year to rear 150,000 bees or about
130 mg pollen consumed for each bee [69] the typical fungicide
exposure a bee receives through pollen can be estimated.
Assuming that most pollen is eaten by nurse bees during the first
10 days of adulthood [69], a nurse bee could be exposed to as
much as 1.3 mg chlorothalonil per day by consuming 13 mg of
pollen containing 99 ppm chlorothalonil [3]. While this dose is
approximately one-eighth the dose of chlorothalonil applied in this
study, we speculate that it may be sufficient to interact with tau-
fluvalinate and thymol. The thymol-chlorothalonil interaction is of
particular concern given the relatively low estimated margin of
safety afforded by thymol formulations (Table 1).
Pollen has been found to contain as much as 1 ppm boscalid
and 0.26 ppm pyraclostrobin [3]. Nurse bees consuming this
pollen may take in as much as 0.015 mg and 0.003 mg per day of
boscalid and pyraclostrobin, respectively, which is three orders of
magnitude less than the doses of boscalid and pyraclostrobin that
demonstrated agonistic interaction with acaricides in this study.
Given the mild interactions observed between these fungicides and
the acaricides, and the relatively low level of these fungicides found
in pollen [3], it seems unlikely to us that adult bees would suffer
acute mortality from PristineTM-acaricide combinations under
field conditions.
The SBI fungicides are also known to enter the hive through
contaminated pollen [57]. Mullin et al. [3] detected the SBI
fungicide myclobutanil at levels as high as approximately 1 ppm in
pollen. At this concentration a nurse bee would be expected to
consume 0.013 mg of myclobutanil per day, which corresponds to
about half the lowest dose of this fungicide administered. A single-
dose exposure to myclobutanil at this level could counter
intuitively protect the bee, to some extent, from tau-fluvalinate
toxicity, possibly through induction of detoxicative enzymes.
However, chronic dietary exposure at this level could lead to
potent synergistic interactions, as we observed at higher fungicide
doses, depending at the rate at which myclobutanil is metabolized
or excreted.
Antimicrobial-acaricide Interactions
Simultaneous exposure to tau-fluvalinate and oxytetracycline,
which blocks multi-drug resistance transporters, has been shown in
previous work to increase tau-fluvalinate toxicity [70]. In our
testing, pretreating bees with oxytetracycline had no significant
effect on the LD50 of tau-fluvalinate; however, the ‘‘pre-treatment
by acaricide dose’’ effect was significant, indicating that the slope is
significantly steeper for bees receiving oxytetracycline treatment
(Table S1). This may be evidence of oxytetracycline effects on the
drug transporter enzymes [70]. While amitraz and oxytetracycline
have been shown to induce programmed cell death in the honey
bee midgut [71], this combination had no effect on acute
mortality.
An antagonistic interaction was observed between fenpyrox-
imate and oxytetracycline. Oxytetracycline has been reported to
have antioxidant properties [72], which may ameliorate the effects
of fenpyroximate, a pesticide known to cause oxidative-stress in
mammals [67].
Between-year Variability
Honey bees treated in 2009 were more tolerant of tau-
fluvalinate than bees in both previous studies [22] and bees
treated in 2010. A study conducted in 2008 using an identical
protocol determined an LD50 for tau-fluvalinate of 6.75 mg per
bee [22]. The LD50 for tau-fluvalinate in 2009 was determined
to be 19.8 mg per bee, which is substantially higher than 9.2 mg
and 9.0 mg per bee determined in 2010 for oral and topical
control pre-treatments, respectively. This substantial difference
in susceptibility to tau-fluvalinate and other acaricides between
years occurred despite the fact that bees were kept in the same
apiary, in the same woodenware, and were collected for
bioassays over the same months of the year and, for the most
part, were subjected to bioassays by the same workers using the
same equipment and technical grade tau-fluvalinate purchased
from the same source. The only obvious difference between
years was the genetic stock as queens in all colonies were
replaced at the beginning of the season in 2010. Elzen et al.
[73], noted that European honey bees (A. mellifera ligustica) were
significantly more tolerant of the pyrethroid cyfluthrin than
African honey bees (A. mellifera scutellata) and suggested that this
difference may be the product of inadvertent selection for
pyrethroid tolerance resulting from the widespread use of tau-
fluvalinate as an acaricide in managed European honey bee
colonies. In the same manner, the observed difference in tau-
fluvalinate toxicity between populations of European honey bees
Table 1. Estimated margins of safety for six acaricides based on estimated daily dosages per bee and the estimated LD10.
formulated
product active ingredient g
treatment
duration
(days)
predicted daily
exposure
(mg/bee)
reported mean
exposure
(mg/bee)
max.
(mg/bee)
LD10
(mg/bee)
estimated
margin
of safety
Apistan tau-fluvalinate 1.4 56 0.13 0.04a 0.70a 3.08 24
Checkmite+ coumaphos 2.8 45 0.31 0.09a 3.20b 12.1 39
Hivastan fenpyroximate 0.7 42 0.40 2 2 2.19 5.5
Apivar amitraz 1.0 42 0.12 0.15a 9.04a 0.92 7.8
ApilifeVar thymol 49 32 7.6 2 2 15.4 2.0
Apiguard thymol 25 28 4.5 2 2 15.4 3.4
oxalic acid 1.8 1 44 2 2 176.7c 4.0
For reported concentrations of acaricides in bees: a = [3], and b= [51]. See the text for methods used to estimate daily exposure. Margins of safety are calculated by
dividing the LD10 dose (Table S1 and c = [76]), by the predicted daily dose.
doi:10.1371/journal.pone.0054092.t001
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may be due to inadvertent selection for tolerance through queen
breeders’ choice of acaricides.
Conclusions
Detoxication by P450s appears to be the basis for the tolerance
bees show toward tau-fluvalinate, coumaphos and fenpyroximate,
but not amitraz or thymol. Any SBI fungicide that inhibits P450-
mediated detoxification has the potential to interact with tau-
fluvalinate, and likely coumaphos and fenpyroximate as well.
Given the large number of pesticides to which bees are potentially
exposed, and the practical impossibility of testing every possible
combination, examining pesticide interaction with P450s holds
promise as a method to simplify pesticide interaction testing in a
rational way. Testing for P450 interactions could serve as the first
‘‘tool’’ in a lab-based ‘‘toolbox’’ testing for potential pesticide
interactions in bees.
While these laboratory bioassays point to potential problems
associated with the various acaricide treatments, any management
recommendations must be based on additional information gained
from field experiments using whole colonies. Lethal-dose bioas-
says, by definition, require the use of doses that are high enough to
cause acute mortality in bees – doses that are often much higher
than bees are likely to encounter under field conditions. However,
documentation of these interactions provides a foundation for
future experiments using field-relevant doses and helps to focus the
limited resources available for field experiments on those pesticide
combinations with the greatest potential to cause harm. The routes
of exposure to acaricides, fungicides and antimicrobials in beehives
may be different from the topical and oral applications used in
these bioassays. The actual exposure bees receive to formulated
acaricides, sequestered acaricides in beeswax, and fungicide
applications in agriculture need to be quantified to accurately
assess the risk posed by interactions. Additionally, bees may
experience sublethal effects that are, by definition, not quantifiable
in lethal dose bioassays, but may have a substantial effect on
colony health [74,75]. Until more is known about the potential for
interaction between acaricides, fungicides and antimicrobials in
the real world it would be prudent for beekeepers to avoid
concurrent use of acaricides that are detoxified by P450s – tau-
fluvalinate, coumaphos, and fenpyroximate – especially in settings
where honey bees may be simultaneously exposed to the P450-
inhibiting SBI fungicides.
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